Is Blackmores Limited a buy at $120?

Could Blackmores Limited be a buy following its 25% fall?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in food supplements company Blackmores Limited (ASX: BKL) have sunk 25% since it announced its 2016 results on 24 August. However, the company reported a 114.5% increase in earnings-per-share (EPS) to $5.81, quite a feat for a $2 billion company, so does today's share price provide a buying opportunity?

Independent director, John Armstrong, seems to think so given he bought $100,000 of stock for $125 per share on Monday.

It seems that the reason for the crash is that the company advised first quarter sales for 2017 will be lower than the prior corresponding period. Sales were $162 million in the first quarter of 2016, which was the lowest quarter for the year and so Blackmores faces an uphill battle to recover and surpass last year's total sales in 2017.

But management said that the drop in revenue is due to softness in its volatile wholesale business with some "retailers destocking and some exporters changing the channels through which they acquire products."

Therefore, the weak start to the year seems like a temporary blip rather than turning point especially given Blackmores has grown sales for the last 14 years.

In 2016, revenue rose by $245.6 million to $717 million with rising Chinese demand driving most of this increase. Sales to Chinese consumers, either directly or indirectly via Australian channels, increased an estimated four-fold to $250 million. Given the size of the market, I think that over time Chinese sales could dwarf the Australian business.

Blackmores is the number one brand for food supplements and vitamins in Australia, Thailand, Malaysia, Singapore and Hong Kong. It has been named the most trusted brand in Australia for eight years running and the company is doing plenty to maintain and extend its dominant position.

In 2016, it opened a flagship store in Bondi and stores in various international airports across South East Asia. It currently has 24 research projects underway including clinical trials and multiple partnerships with universities.

Blackmores' brand is a source of sustainable competitive advantage and the company has delivered exceptional financial returns to date under the guidance of CEO of the year, Christine Holgate. In 2016 the company reported a staggering 39.9% return on assets and 56.1% return on equity.

Blackmores had $17.8 million of net debt at 30 June 2016 which is insignificant in the context of its $2.1 billion market capitalisation. The company is trading on a historical price-to-earnings ratio (PER) of 21 which looks undemanding given its recent earnings growth and the potential of its Chinese business.

It might also be worth taking a look at Bellamy's Australia Ltd (ASX: BAL) and a2 Milk Company Ltd (Australia) (ASX: A2M) which are also taking advantage of recent free trade agreements with China.

Motley Fool contributor Matt Brazier owns shares of Bellamy's Australia. The Motley Fool Australia owns shares of A2 Milk and Bellamy's Australia. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »